Effect of tranilast on matrix metalloproteinase production from neutrophils in-vitro

Journal of Pharmacy and Pharmacology

Volumn 58, Issue 1, 2006, Pages 91-99

  Shimizu, Toshiyuki ^a   Kanai, Ken Ichi ^a   Kyo, Yoshiyuki ^a   Asano, Kazuhito ^a   Hisamitsu, Tadashi ^a   Suzaki, Harumi ^a  

^a SHOWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIALLERGIC AGENT; GELATINASE B; HISTAMINE; LEUKOTRIENE; LIPOPOLYSACCHARIDE; MATRILYSIN; MATRIX METALLOPROTEINASE; MESSENGER RNA; NEUTROPHIL COLLAGENASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRANILAST; TRANSCRIPTION FACTOR;

ALLERGIC REACTION; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HISTAMINE RELEASE; HUMAN; HUMAN CELL; HYPERTROPHIC SCAR; IN VITRO STUDY; INFLAMMATORY CELL; KELOID; MAST CELL; MEDIATOR RELEASE; NEUTROPHIL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; ANTHRANILIC ACIDS; ANTI-ALLERGIC AGENTS; CELL MOVEMENT; CELLS, CULTURED; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; LIPOPOLYSACCHARIDES; MALE; MATRIX METALLOPROTEINASE 7; MATRIX METALLOPROTEINASE 8; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; NEUTROPHILS; NF-KAPPA B; RNA, MESSENGER; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

EID: 29944434304     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/jpp.58.1.0011     Document Type: Article

References (36)

1. Amour, A., Slocombe, P. M., Webster, A., Butler, M., Knight, C. G., Smith, B. J., Stephens, P. E., Shelley, C., Hutton, M., Knauper, V., Docherty, A. J. P., Murphy, G. (1998) TNF-α converting enzyme (TACE) is inhibited by TIMP-3. FEBS Lett. 435: 39-44
2. Arechavaleta-Velasco, F., Marciano, D., Diaz-Cueto, L., Parry, S. (2004) Matrix metalloproteinase-8 is expressed in human chorion during labor. Am. J. Obstet. Gynecol. 190: 843-850
3. Attiga, F. A., Fernandez, P. M., Weeraratna, A. T. Manyak, M. J., Patierno, S. R. (2000) Inhibitors of prostaglandin synthesis inhibit human prostate tumor cell invasiveness and reduce the release of matrix metalloproteinases. Cancer Res. 60: 4629-4637
4. Azuma, H., Banno, K., Yoshimura, T. (1976) Pharmacological properties of N-(3′, 4-dimetoxycinnamoyl) antharanilic acid (N-5′), a new anti-atopic agent. Br. J. Pharmacol. 58: 483-488
5. Barille, S., Bataille, R., Rapp, M. J., Harusseau, J. L., Amiot, M. (1999) Production of metalloproteinase-7 (matrilysin) by human myeloma cells and its potential involvement in metalloproteinase-2 activation. J. Immunol. 163: 5723-5728
6. Birkedal-Hansen, H. (1995) Proteolytic remodeling of extracellular matrix. Curr. Opin. Cell Biol. 7: 728-735
7. Capper, E. A., Roshak, A. K., Bolognes, B. J., Podolin, P. L., Smith, T., Dewitt, D. L., Anderson, K. M., Marshall, L. A. (2000) Modulation of human monocytes activities by tranilast, SB252218, a compound demonstrating efficacy in restenosis. J. Pharmacol. Exp. Ther. 295: 1061-1069
8. Chikaraishi, A., Hirahashi, J., Takase, O., Marumo, T., Hishikawa, K., Hayashi, M., Saruta, T. (2001) Tranilast inhibits interleukin-1β-induced monocytes chemoattractants protein-1 expression in rat mesangial cells. Eur. J. Pharmacol. 427: 151-158
9. DiBattista, J. A., Martel-Pelletier, J., Fujimoto, N., Obata, K., Zafarullah, M., Pelletier, J. P. (1994) Prostaglandins E2 and E1 inhibit cytokine-induced metalloproteinase expression in human synovial fibroblasts. Mediation by cyclic-AMP signaling pathway. Lab. Invest. 71: 270-278
10. Domeiji, H., Yucel-Lindberg, T., Modeer, T. (2002) Signal pathways involved in the production of MMP-1 and MMP-3 in human gingival fibroblasts. Eur. J. Oral Sci. 110: 302-306
11. Edward, D. R., Rocheleau, H., Sharma, R. R. Willis, A. J., Cowie, A., Hassell, J. A., Heath, J. K. (1992) Involvement of AP-1 and PEA3 binding sites in the regulation of murine tissue inhibitor of metalloproteinase-1 (TIMP-1) transcription. Biochim. Biophys. Acta 1171: 41-55
12. Gomez, D. E., Alonso, D. F., Yoshiji, H., Thorgeirsson, U. P. (1997) Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. Eur. J. Cell Biol. 74: 111-122
13. Hashimoto, N., Kawabe, T., Hara, T., Imaizumi, K., Wakayama, H., Saito, H., Shimokata, K., Hasegawa, Y. (2001) Effect of erythromycin on matrix metalloproteinase-9 and cell migration. J. Lab. Clin. Med. 137: 176-183
14. Herbst, H., Wege, T., Milani, S., Pellegrini, G., Orzechowski, H. D., Bechstein, W. O., Neuhause, P., Gressner, A. M., Schuppan, D. (1997) Tissue inhibitor of metalloproteinase-1 and -2 RNA expression in rat and human liver fibrosis. Am. J. Pathol 150: 1647-1659
15. Hoshino, M., Nakamura, Y., Sim, J. J., Shimojo, J., Isogai, S. (1998) Bronchial subepithelial fibrosis and expression of matrix metalloproteinase-9 in asthmatic airway inflammation. J. Allergy Clin. Immunol. 102: 783-788
16. Huang, F. M., Yang, S. F., Hsieh, Y. S. Liu, C. M., Yang, L. C., Chang, Y. C. (2004) Examination of the signal transduction pathway involved in matrix metalloproteinase-2 in human pulp cells. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endol. 97: 398-403
17. Isaji, M., Aruga, N., Naito, J., Miyata, H. (1994) Inhibition by tranilast of collagen accumulation in hypersensitive granulomatous inflammation in vivo and of morphological changes and functions of fibroblasts in vitro. Life Sci. 55: PL287-PL292
18. Isaji, M., Miyata, H., Ajisawa, Y., Takehana, Y., Yoshimura, N. (1997) Tranilast inhibits the proliferation, chemotaxis and tube formation of human microvascular endothelial cells in vitro and angiogenesis in vivo. Br. J. Pharmacol. 122: 1061-1066
19. Kanai, K., Asano, K., Hisamitsu, T., Suzaki, H. (2004a) Suppression of matrix metalloproteinase production from nasal fibroblasts by macrolide antibiotics in vitro. Eur. Respir. J. 23: 671-678
20. Kanai, K., Asano, K., Hisamitsu, H., Suzaki, K. (2004b) Suppression of matrix metalloproteinase-9 production from neutrophils by a macrolide antibiotic, roxithromycin in vitro. Med. Inflamm. 14: 313-320
21. Kim, K. H., Burkhart, K., Chen, P., Frevert, C. W., Randorph-Habecker, J., Hackman, R. C., Soloway, P. D., Madtes, D. K. (2005) Tissue inhibitor of metalloproteinase-1 deficiency amplifies acute lung injury in bleomycin-exposed mice. Am. J. Respir. Cell Mol. Biol. 33: 271-279
22. Lavigne, M. C., Eppihimer, M. J. (2005) Cigarette smoke condensate induces MMP-12 gene expression in airway-like epithelia. Biochem. Biophys. Res. Commun. 330: 194-203
23. Maita, E., Sato, M., Yamaki, K. (2004) Effect of tranilast on matrix metalloproteinase-1 secretion from human gingival fibroblasts in vitro. J. Periodontol. 75: 1054-1060
24. Matsuyama, W., Wang, L., Farrar, W. L., Faure, M., Yoshimura, T. (2005) Activation of discoidin domain receptor 1 isoform b with collagen up-regulates chemokine production in human macrophages: Role of p38 mitogen-activated protein kinase and NF-κB. J. Immunol. 172: 2332-2340
25. Nagase, H., Woessner, J. F. (1999) Matrix metalloproteinases. J. Biol. Chem. 31: 21491-21494
26. Okamoto, S. I., Mukaida, N., Yasumoto, K., Rice, N., Ishikawa, Y., Horiguchi, H., Murakami, S., Matsushima, K. (1994) The interleukin-8 AP-1 and κB-like sites are genetic end targets of FK-506-sensitive pathway accompanied by calcium mobilization. J. Biol. Chem. 269: 8582-8589
27. Ohno, I., Ohtani, H., Nitta, Y. (1997) Eosinophils as a source of matrix metalloproteinase-9 in asthmatic airway inflammation. Am. J. Respir. Cell Mol. Biol. 16: 212-219
28. Pillinger, M. H., Rosenthal, P. B., Tolani, S. N., Apsel, B., Dinsell, V., Greenberg, J., Chan, E. S., Gomez, P. F., Abramson, S. B. (2003) Cyclooxygenase-2-derived E prostaglandins down-regulate matrix metalloproteinase-1 expression in fibroblast-like synoviocytes via inhibition of extracellular signal-regulated kinase activation. J. Immunol. 171: 6080-6089
29. Redd, M. J., Cooper, L., Wood, W., Stramer, B., Martin, P. (2004) Wound healing and inflammation: embryos reveal the way to perfect repair. Phil. Trans R. Soc. Lond. B Biol. Sci. 359: 777-784
30. Richardson, M. (2004) Acute wounds: an overview of the physiological healing process. Nurs. Times 100: 50-53
31. Salib, R. J., Howarth, P. H. (2003) Remodelling of the upper airways in allergic rhinitis: is it a feature of the disease? Clin. Exp. Allergy 33: 1629-1633
32. Sato, H., Seiki, M. (1993) Regulatory mechanism of 92 kDa type IV collagenase gene expression, which is associated with invasiveness of tumor cells. Oncogene 8: 395-405
33. Shimizu, T., Kanai, K., Asano, K., Hisamitsu, T., Suzaki, H. (2005) Suppression of matrix metalloproteinase production in nasal fibroblasts by tranilast, an antiallergic agent, in vitro. Mediators Inflamm. 2005: 150-159
34. Suzawa, H., Kikuchi, S., Arai, N., Koda, A. (1992a) The mechanism involved in the inhibitory action of tranilast on collagen biosynthesis of keloid fibroblasts. Jpn. J. Pharmacol. 60: 91-96
35. Suzawa, H., Kikuchi, S., Ichikawa, K., Arai N., Tazawa, S., Tsuchiya, O., Momose, Y., Shibata, N., Sugimoto, C., Hamano, S. (1992b) Effect of tranilast, an anti-allergic drug, on the keloid tissues. Nippon Yakugaku Zasshi 99: 231-239
36. Ukai, K., Masuda, S., Shinoki, J., Mayumi, H., Sakakura Y. (1993) Clinical and pathophysiological evaluation of tranilast in patients with pollinosis: the effects of pre-seasonal treatment. Auris Nasus Larynx 20: 275-284